ABVC
ABVC BioPharma·NASDAQ
--
--(--)
--
--(--)
7.50 / 10
Outperform
Liquidity flow evaluation: 7.5/10 demonstrating robust fund flow characteristics. Optimistic Medium patterns are mitigated by pessimistic overall, block, Small, Large, and Extra-large indicators, pointing to positive flow perspective.
Fund Flow Rating
What is the analyst consensus for ABVC?
- ABVC holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.50/10 (Outperform).
